Phathom Pharmaceuticals, Inc. Annual Depreciation in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Phathom Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2022.
  • Phathom Pharmaceuticals, Inc. Depreciation for the quarter ending September 30, 2023 was $100K, a 50% decline year-over-year.
  • Phathom Pharmaceuticals, Inc. Depreciation for the twelve months ending September 30, 2023 was $500K, a 2.72% decline year-over-year.
  • Phathom Pharmaceuticals, Inc. annual Depreciation for 2022 was $600K, a 20% increase from 2021.
  • Phathom Pharmaceuticals, Inc. annual Depreciation for 2021 was $500K, a 66.7% increase from 2020.
  • Phathom Pharmaceuticals, Inc. annual Depreciation for 2020 was $300K, a 3650% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $600K +$100K +20% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-28
2021 $500K +$200K +66.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $300K +$292K +3650% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $8K +$8K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.